Real-world effects, safety, and predictors of the effectiveness of romosozumab in primary and secondary osteoporosis: An observational study.
第一作者:
Kazuaki,Mineta
第一单位:
Department of Orthopaedic Surgery, Tokushima Kensei Hospital, 4-9 Shimosuketo-cho, Tokushima 770-8547, Japan.
作者:
医学主题词
人类(Humans);女(雌)性(Female);男(雄)性(Male);老年人(Aged);骨质疏松(Osteoporosis);骨密度(Bone Density);抗体, 单克隆(Antibodies, Monoclonal);中年人(Middle Aged);治疗结果(Treatment Outcome);老年人, 80以上(Aged, 80 and over);骨密度保护剂(Bone Density Conservation Agents)
DOI
10.1016/j.bone.2024.117164
PMID
38871265
发布时间
2024-07-09
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



